The Effect of Shotblocker on Pain Violence and Injection Sat... | Clinical Trial | StuddyBuddy@endsection
← Back to all trials
Completed
NCT05647239
The Effect of Shotblocker on Pain Violence and Injection Satisfaction
Conditions: Pain
Sex: All
Ages: 18 Years – 65 Years
Phase: NA
Enrollment: 120
Sponsor: TC Erciyes University
Location: Turkey
Summary
This study was conducted to determine the effect of Shotblocker on pain level and injection satisfaction in SC injection administrations.
The study was completed with 120 patients who were hospitalized in orthopedic clinic of a training and research hospital to receive treatment and met the inclusion criteria of the study.
In addition to Standard practices for the clinic, the individuals in the intervention group received LMWH treatments via Shotblocker three times as once per day by administering SC from theside of the patients' upper armand thetreatment made with there ady injector of LMWH was ended within 20 seconds and the light pressure was applied to the injection site for 30 seconds. .
Eligibility Criteria
Inclusion Criteria:Individuals whose treatment plan was Clexane 1x1 0.6 mg subcutaneous,Who were over 18 years of age,Who were conscious,Who had cognitive competence to answer the questionnaire,Who had no vision and hearing loss,Who had no bleeding clotting disorder,Who had platelet, INR and APTT values within normal limits,Who had no signs of scar tissue, incision or infection in the injection site,Who had no allergy history and agreed to participate in the study were included in the study.Exclusion Criteria:The patients, who had amputation in the right/left arm region to be injected,Who had any scar tissue, incision, lipodystrophy or infection symptom on the injection site in the arm area,Who received hemodialysis treatment and had dialysis catheter,Who underwent mastectomy surgery and should not receive any practice/treatment on the arm on the operated side, were excluded from the study.
Source: ClinicalTrials.gov (NCT05647239). StuddyBuddy aggregates publicly available trial information.